Insulin signaling alters antioxidant capacity in the diabetic heart.
Cardiomyocytes
Diabetes
EPR
Heart
Insulin
Thioredoxin
Journal
Redox biology
ISSN: 2213-2317
Titre abrégé: Redox Biol
Pays: Netherlands
ID NLM: 101605639
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
received:
26
08
2021
revised:
14
09
2021
accepted:
16
09
2021
pubmed:
25
9
2021
medline:
1
12
2021
entrez:
24
9
2021
Statut:
ppublish
Résumé
Diabetic cardiomyopathy is associated with an increase in oxidative stress. However, antioxidant therapy has shown a limited capacity to mitigate disease pathology. The molecular mechanisms responsible for the modulation of reactive oxygen species (ROS) production and clearance must be better defined. The objective of this study was to determine how insulin affects superoxide radical (O
Identifiants
pubmed: 34560411
pii: S2213-2317(21)00299-8
doi: 10.1016/j.redox.2021.102140
pmc: PMC8473541
pii:
doi:
Substances chimiques
Antioxidants
0
Insulin
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
102140Subventions
Organisme : NIGMS NIH HHS
ID : P20 GM103447
Pays : United States
Organisme : NIGMS NIH HHS
ID : R24 GM137786
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL125625
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG050911
Pays : United States
Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.